InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,308.13
(
0.09%
)
US TECH 100
18,178.40
(
-0.10%
)
Dow Jones
39,806.77
(
-0.49%
)
Brent Oil
82.92
(
-0.74%
)
Bitcoin
70,962.79
(
-0.68%
)
Post# of 251866
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: skitahoe post# 105237

Tuesday, 09/28/2010 1:41:09 PM

Tuesday, September 28, 2010 1:41:09 PM

Post# of 251866
IMGN has exactly one success out of almost a dozen tries. SGEN has one success out of one try. IMGN has far more TAP compounds in trials by partners currently. SGEN has two or three.

This is an argument people can legitimately have differences of opinion over. Remember I think TAP works, too.

Unless otherwise indicated, this is the personal viewpoint of David
Miller and not necessarily that of Biotech Stock Research, LLC.
We're on Twitter at BiotechStockRsr

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up